(PRKS) United Parks & Resorts - Overview
Stock: Theme Parks, Water Parks, Marine Life, Safari, Sesame Street
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 41.5% |
| Relative Tail Risk | -5.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.54 |
| Alpha | -49.21 |
| Character TTM | |
|---|---|
| Beta | 1.357 |
| Beta Downside | 1.371 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.44% |
| CAGR/Max DD | -0.32 |
Description: PRKS United Parks & Resorts January 13, 2026
United Parks & Resorts Inc. (NYSE: PRKS) operates a portfolio of themed attractions across the United States and one international location (Abu Dhabi). Its brands include SeaWorld, Busch Gardens, Aquatica, Discovery Cove, Water Country USA, Adventure Island, and Sesame Place, covering marine-life parks, traditional amusement parks, and water-park experiences. The company rebranded from SeaWorld Entertainment in February 2024, but its core assets-SeaWorld parks in Orlando, San Antonio, San Diego, and Abu Dhabi; Busch Gardens in Tampa and Williamsburg; plus a network of water-park venues-remain unchanged.
Key operational metrics (2023) show total revenue of roughly $2.3 billion, with an adjusted EBITDA margin near 12 % and an average annual attendance of about 30 million guests, reflecting the sector’s sensitivity to discretionary consumer spending and macro-economic factors such as employment rates and consumer confidence. Recent earnings releases indicate a 4 % YoY increase in per-guest spend, driven partly by higher ticket-price elasticity and expanded premium-experience offerings (e.g., behind-the-scenes tours and animal-encounter packages).
Industry drivers that will likely impact PRKS’s outlook include the broader leisure-facility GICS sub-industry’s rebound from pandemic-related closures, with the U.S. amusement-park market projected to grow 5 % CAGR through 2028, and the company’s exposure to weather-related attendance volatility in its water-park segment. Additionally, the ongoing debate over animal-welfare practices introduces regulatory and reputational risk, which could affect licensing costs and visitor sentiment.
For a deeper quantitative breakdown, you might explore the companys metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 181.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.03 > 1.0 |
| NWC/Revenue: 1.91% < 20% (prev -8.23%; Δ 10.13% < -1%) |
| CFO/TA 0.15 > 3% & CFO 414.2m > Net Income 181.2m |
| Net Debt (2.17b) to EBITDA (555.1m): 3.91 < 3 |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.4m) vs 12m ago -3.84% < -2% |
| Gross Margin: 92.28% > 18% (prev 0.92%; Δ 9136 % > 0.5%) |
| Asset Turnover: 62.91% > 50% (prev 67.06%; Δ -4.15% > 0%) |
| Interest Coverage Ratio: 2.53 > 6 (EBITDA TTM 555.1m / Interest Expense TTM 151.5m) |
Altman Z'' 2.26
| A: 0.01 (Total Current Assets 406.9m - Total Current Liabilities 375.0m) / Total Assets 2.74b |
| B: 0.29 (Retained Earnings 790.9m / Total Assets 2.74b) |
| C: 0.14 (EBIT TTM 383.3m / Avg Total Assets 2.66b) |
| D: 0.26 (Book Value of Equity 791.9m / Total Liabilities 3.05b) |
| Altman-Z'' Score: 2.26 = BBB |
Beneish M -3.14
| DSRI: 1.02 (Receivables 85.1m/86.6m, Revenue 1.67b/1.73b) |
| GMI: 1.00 (GM 92.28% / 92.36%) |
| AQI: 0.97 (AQ_t 0.11 / AQ_t-1 0.11) |
| SGI: 0.97 (Revenue 1.67b / 1.73b) |
| TATA: -0.09 (NI 181.2m - CFO 414.2m) / TA 2.74b) |
| Beneish M-Score: -3.14 (Cap -4..+1) = AA |
What is the price of PRKS shares?
Over the past week, the price has changed by -1.65%, over one month by +0.63%, over three months by +5.38% and over the past year by -30.71%.
Is PRKS a buy, sell or hold?
- StrongBuy: 5
- Buy: 0
- Hold: 6
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the PRKS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.9 | 21.3% |
| Analysts Target Price | 44.9 | 21.3% |
| ValueRay Target Price | 35.9 | -3.1% |
PRKS Fundamental Data Overview February 03, 2026
P/E Forward = 7.5075
P/S = 1.238
P/B = 181.6626
Revenue TTM = 1.67b USD
EBIT TTM = 383.3m USD
EBITDA TTM = 555.1m USD
Long Term Debt = 2.22b USD (from longTermDebt, last quarter)
Short Term Debt = 19.6m USD (from shortTermDebt, last quarter)
Debt = 2.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.17b USD (from netDebt column, last quarter)
Enterprise Value = 4.24b USD (2.07b + Debt 2.35b - CCE 183.2m)
Interest Coverage Ratio = 2.53 (Ebit TTM 383.3m / Interest Expense TTM 151.5m)
EV/FCF = 19.21x (Enterprise Value 4.24b / FCF TTM 220.7m)
FCF Yield = 5.20% (FCF TTM 220.7m / Enterprise Value 4.24b)
FCF Margin = 13.19% (FCF TTM 220.7m / Revenue TTM 1.67b)
Net Margin = 10.83% (Net Income TTM 181.2m / Revenue TTM 1.67b)
Gross Margin = 92.28% ((Revenue TTM 1.67b - Cost of Revenue TTM 129.1m) / Revenue TTM)
Gross Margin QoQ = 92.20% (prev 92.42%)
Tobins Q-Ratio = 1.55 (Enterprise Value 4.24b / Total Assets 2.74b)
Interest Expense / Debt = 1.42% (Interest Expense 33.5m / Debt 2.35b)
Taxrate = 24.52% (29.0m / 118.3m)
NOPAT = 289.3m (EBIT 383.3m * (1 - 24.52%))
Current Ratio = 1.09 (Total Current Assets 406.9m / Total Current Liabilities 375.0m)
Debt / Equity = -7.62 (negative equity) (Debt 2.35b / totalStockholderEquity, last quarter -308.7m)
Debt / EBITDA = 3.91 (Net Debt 2.17b / EBITDA 555.1m)
Debt / FCF = 9.83 (Net Debt 2.17b / FCF TTM 220.7m)
Total Stockholder Equity = -410.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.81% (Net Income 181.2m / Total Assets 2.74b)
RoE = -44.10% (negative equity) (Net Income TTM 181.2m / Total Stockholder Equity -410.9m)
RoCE = 21.18% (EBIT 383.3m / Capital Employed (Equity -410.9m + L.T.Debt 2.22b))
RoIC = 15.82% (NOPAT 289.3m / Invested Capital 1.83b)
WACC = 5.68% (E(2.07b)/V(4.42b) * Re(10.91%) + D(2.35b)/V(4.42b) * Rd(1.42%) * (1-Tc(0.25)))
Discount Rate = 10.91% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -7.42%
[DCF Debug] Terminal Value 84.45% ; FCFF base≈204.9m ; Y1≈173.0m ; Y5≈130.5m
Fair Price DCF = 33.18 (EV 3.98b - Net Debt 2.17b = Equity 1.81b / Shares 54.6m; r=5.90% [WACC]; 5y FCF grow -18.88% → 2.90% )
EPS Correlation: -1.61 | EPS CAGR: 10.87% | SUE: -2.01 | # QB: 0
Revenue Correlation: 16.31 | Revenue CAGR: 8.98% | SUE: -2.77 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.20 | Chg30d=-0.082 | Revisions Net=-1 | Analysts=3
EPS next Year (2026-12-31): EPS=3.85 | Chg30d=-1.252 | Revisions Net=-2 | Growth EPS=+2.8% | Growth Revenue=+2.1%